Puma Biotechnology, Inc : Puma Biotechnology and Pierre Fabre Amend NERLYNX License Agreement to Include Greater China finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Share:
Stone Ridge, VA, February 20, 2021 (PR.com) Tigerlily Foundation in partnership with Puma Biotechnology, Inc. is excited to announce the launch of BREATHE Tv. BREATHE Tv is a sacred space, an educational and inspirational breast cancer lifestyle television series that brings together patients and providers in a space of purpose, while engaging in authentic and meaningful conversations about cancer.
The first episode of BREATHE Tv launched on Friday, January 29, 2021 on Tigerlily’s Facebook page. The series is hosted by Maimah Karmo, Breast Cancer Survivor & Founder of Tigerlily Foundation.
Episodes:
A cancer diagnosis can feel overwhelming. In an instant, you’re thrust into a world that is completely foreign to you, without an anchor and oftentimes without a guide. In this first episode “From “Fearful to Fearless - Getting Educated About Your Cancer,” Ines Rodriguez, Breast Cancer Survivor and Clinical Nurse Educator, Puma Biotechnology, does what she does bes
Search jobs Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
LOS ANGELES (BUSINESS WIRE) Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on February 4, 2021 the Compensation Committee of Puma’s Board of Directors approved the grant of inducement restricted stock unit awards covering an aggregate of 11,000 shares of Puma common stock to two new non-executive employees.
The awards were granted under Puma’s 2017 Employment Inducement Incentive Award Plan, which was adopted on April 27, 2017 and provides for the granting of equity awards to new employees of Puma. The restricted stock unit awards vest over a three-year period, with one-third of the shares underlying each award vesting on the first anniversary of the award’s vesting commencement date, February 1, 2021, and one-sixth of the shares underlying each award vesting on each six-month anniversary of the vesting commencement dat
Press release content from Business Wire. The AP news staff was not involved in its creation.
ONK Therapeutics Appoints Hugh O’Dowd as Independent Chairman
January 14, 2021 GMT
GALWAY, Ireland & SAN DIEGO (BUSINESS WIRE) Jan 14, 2021
ONK Therapeutics Ltd, an innovative natural killer (NK) cell therapy company, today announced that it has appointed Hugh O’Dowd as Director and independent Non-executive Chairman of its Board of Directors.
US-based Mr. O’Dowd brings significant experience and a background in the life sciences industry to the ONK Therapeutics’ Board in particular building organizations and commercialization of oncology therapeutics. His experience and strategic insights will be invaluable to ONK as it executes on its growth ambitions, progressing its novel, off-the-shelf, dual-targeted, natural killer (NK) cell therapy platform towards human clinical trials.